Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
AUTOR(ES)
Fujiyoshi, K
RESUMO
Arginine-vasopressin (AVP) concentrations in five cortical areas were measured post mortem in nine patients with senile dementia of Alzheimer's type (SDAT), and compared with the control group of comparable ages. In SDAT patients, AVP was significantly reduced in Brodmann areas 4, 7 and 10 (p less than 0.05). In areas 17 and 22, the detectability and the mean concentrations of AVP were also lower than those of control patients, although not significantly.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1032137Documentos Relacionados
- Correlation between diffuse EEG abnormalities and cerebral atrophy in senile dementia.
- Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
- Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
- Use of computerized tomography in senile dementia.
- Cytophotometric mapping of neuronal changes in senile dementia.
